Details for New Drug Application (NDA): 050594
✉ Email this page to a colleague
NDA 050594 describes ERYCETTE, which is a drug marketed by Johnson And Johnson and is included in one NDA. Additional details are available on the ERYCETTE profile page.
The generic ingredient in ERYCETTE is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
The generic ingredient in ERYCETTE is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050594
| Tradename: | ERYCETTE |
| Applicant: | Johnson And Johnson |
| Ingredient: | erythromycin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050594
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SWAB;TOPICAL | Strength | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Feb 15, 1985 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
